News

IQVIA Launches New AI Agents for Life Sciences and Healthcare
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...
Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis
Achieves FDA Alignment on CMC and Non-Clinical Toxicology Regulatory Path for Nebokitug in PSC— —Preparations for the Nebokitug PSC Phase 3 Clinical Trial Advance as Discussions with Potential ...
How close are we to getting a vaccine for Lyme disease?
Diana Moser has, to the best of her knowledge, not contracted Lyme disease, a welcome status quo that might be credited to ...
Alzheimer's Disease Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
DelveInsight's Alzheimer's Disease Pipeline report depicts a robust space with 200+ active players working to develop 220+ ...
Crispr Therapeutics: Early-Stage Research Updates Show Promise
Crispr Therapeutics' current revenue from CASGEVY is limited by high costs, profit-sharing, and logistical hurdles. Click ...
Esquire Philippines on MSN16h
Today I Learned: Nighttime Scrolling Delays Sleep More Than a Double Espresso
Your bedtime screen time is not just delaying your sleep, it’s ruining your sleep cycle and mental health. And if you think ...
Medindia16h
Hot Flashes & Hope: Is Duavee the Cancer Shield?
Duavee, approved for menopause, may help prevent invasive breast cancer by slowing cell growth in breast cancer, offering a ...
BioPharma Dive8h
Insmed surges on lung drug data; Recursion cuts staff
Insmed shares rocketed on results for a pulmonary arterial hypertension drug that exceeded Wall Street expectations.
Worldwide Healthcare Trust PLC - Annual Financial Report
Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...